1. Home
  2. CBNK vs CADL Comparison

CBNK vs CADL Comparison

Compare CBNK & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CBNK

Capital Bancorp Inc.

N/A

Current Price

$42.10

Market Cap

560.3M

Sector

Finance

ML Signal

N/A

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$9.17

Market Cap

641.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CBNK
CADL
Founded
1974
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
560.3M
641.2M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
CBNK
CADL
Price
$42.10
$9.17
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
★ $44.08
$22.11
AVG Volume (30 Days)
136.9K
★ 1.1M
Earning Date
10-26-2026
11-24-2026
Dividend Yield
★ 1.31%
N/A
EPS Growth
★ 60.85
58.62
EPS
★ 2.40
N/A
Revenue
N/A
★ $125,000.00
Revenue This Year
$8.98
N/A
Revenue Next Year
$10.68
N/A
P/E Ratio
$17.82
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.40
$4.35
52 Week High
$44.76
$14.00

Technical Indicators

Market Signals
Indicator
CBNK
CADL
Relative Strength Index (RSI) 58.96 50.88
Support Level $35.70 $7.70
Resistance Level N/A $9.42
Average True Range (ATR) 0.94 0.65
MACD -0.05 0.20
Stochastic Oscillator 40.77 68.69

Price Performance

Historical Comparison
CBNK
CADL

About CBNK Capital Bancorp Inc.

Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage. The company generates majority revenue from the Commercial bank sector. Commercial Banking division focuses on providing personalized service to commercial clients throughout the operations supplemented by lending outside primary market as well as engaging in government guaranteed lending on a national basis.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: